Biotech

All Articles

TPG tops up funds to $580M for expenditures all over life sciences

.Resource supervisor TPG, which has supported biotechs like Sionna Rehabs as well as Santa Ana Biogr...

Merck ceases phase 3 TIGIT trial in bronchi cancer for impossibility

.Merck &amp Co.'s TIGIT course has experienced another obstacle. Months after shuttering a stage 3 c...

After a difficult year, Exscientia folds right into Recursion

.After a year determined through pipe cuts, the departure of its own chief executive officer as well...

Cullinan, after $25M offer, hands back bispecific to Harbour

.Cullinan Therapy was actually excited enough along with Port BioMed's bispecific immune system reac...

A better consider Fierce Biotech's Intense 15

.In this particular full week's incident of "The Top Pipe," our team are actually diving into Brutal...

Lilly encounters phase 2 failing of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's celebration celebrating the approval ...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of notable management hirings, shootings and ret...

Lykos will certainly talk to FDA to rethink its decision observing rejection of MDMA treatment for trauma

.Adhering to a bad showing for Lykos Therapeutics' MDMA applicant for post-traumatic stress disorder...

AN 2 halves census, quits period 3 test after information disappoint

.AN2 Rehabs is actually re-thinking its own organization in action to dull midphase data, promising ...

Merck pays for $700M for bispecific, snooping autoimmune opening as well as opportunity to test Amgen in cancer

.Merck &amp Co. is actually paying out $700 thousand in advance to test Amgen in a blood cancer cell...